Key drivers for each region include: for North America, investments in research and development, favorable policies, and a mature ecosystem; for Europe, growing demographics of the aging population, increasing infrastructure for healthcare, and rising awareness of red light therapy benefits; for Asia Pacific, expanding middle class, increasing access to healthcare, and government initiatives to promote the use of red light therapy devices; for Latin America, growing demand for non-invasive treatments, increasing partnerships between healthcare providers and device manufacturers, and improving economic conditions; and for Middle East & Africa, rising healthcare expenditure, increasing focus on preventive care, and growing interest in alternative therapies.